Gill Farrar

Amersham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Journal: JAMA

Published: July 13, 2026

Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study.

Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study.

Journal: Alzheimer's research & therapy

Published: February 05, 2026

Cortical gray-white matter contrast alterations precede amyloid-β positivity and macrostructural changes in older adults without dementia.

Cortical gray-white matter contrast alterations precede amyloid-β positivity and macrostructural changes in older adults without dementia.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 29, 2026

Comparability of Centiloid values from [18F]flutemetamol scans using seven commercial and research software.

Comparability of Centiloid values from [18F]flutemetamol scans using seven commercial and research software.

Journal: Neuroimage. Reports

Published: December 18, 2025

Let's celebrate 25 years of [123I]I-FP-CIT SPECT.

Let's celebrate 25 years of [123I]I-FP-CIT SPECT.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 02, 2025

AI-enhanced Centiloid quantification of amyloid PET images.

AI-enhanced Centiloid quantification of amyloid PET images.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 14, 2025

Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges.

Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: August 14, 2025

Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History study.

Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History study.

Journal: NeuroImage. Clinical

Published: August 12, 2025

Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinning.

Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinning.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 09, 2025

Heterogeneity of dementia with lewy bodies: Insights from clinical presentations, neuropathology, and biomarkers.

Heterogeneity of dementia with lewy bodies: Insights from clinical presentations, neuropathology, and biomarkers.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 19, 2025

System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatment.

System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatment.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: December 11, 2024

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 10, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026